New Zealand brand WOVOW enters the Chinese market - creating a new highland of dietary nutrition with pharmaceutical concepts

In the wave of globalization, WOVOW, a heavyweight dietary nutrition brand under New Zealand Biopharmaceutical Group Limited, has entered the Chinese market. As a 70 year old local pharmaceutical group in New Zealand, it is taking an important step towards expanding the global dietary nutrition landscape. As a leader in the field of cellular immune nutrition, WOVOW is committed to providing professional health solutions to global consumers and improving the quality of human life cycle.
New Zealand Biopharmaceutical Group Co., Ltd., rooted in the biomedical cell medicine research and development industry, comprehensively applies the principles and methods of life science and engineering science to understand the structure, function and other life phenomena of the human body at multiple levels in molecules, cells, tissues, organs and even the whole human system, focusing on helping to deal with immune deficiency, long-term sequelae of COVID-19, cardiovascular and cerebrovascular problems Respiratory infections and other major health issues that are of global concern and face. Pharmaceutical companies have natural advantages in entering the dietary nutrition industry. WOVOW adheres to the group's 70 year pharmaceutical philosophy of "safety, people-oriented, cutting-edge, and scientific", and strives to do a good job in dietary nutrition with a rigorous attitude.